No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
677 |
4. Check minimum number of eventsNone |
677 |
5. Include endpointsNone |
677 |
6. Filter based on genotype QC (FinnGen only) |
605 |
Control definitions (FinnGen only)
- Control exclude
- H8_INNER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H81
- Name in latin
- Vertigo centralis
Similar endpoints
↥List of similar endpoints to
Vertigo of central origin
based on the number of shared cases.
Similar with more cases:
- Disorders of vestibular function (Vertigo)
- Diseases of inner ear
- Diseases of the ear and mastoid process
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4801 | 3024 | 1740 |
| Only index persons | 3769 | 2372 | 1397 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.09 | 0.05 |
| Only index persons | 0.07 | 0.09 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 70.36 | 71.94 | 67.46 |
| Only index persons | 66.62 | 67.92 | 64.42 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 605 | 367 | 238 |
| Unadjusted period prevalence (%) | 0.12 | 0.13 | 0.11 |
| Median age at first event (years) | 63.03 | 61.21 | 65.84 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 627
- Matched controls
- 6270
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H81.4
ICD-10 Finland
Vertigo of central origin
4503599627370496.0
307.7
626
11
R42
ICD-10 Finland
Dizziness and giddiness
14.6
250.0
452
945
H81.3
ICD-10 Finland
Other peripheral vertigo
50.9
169.1
99
23
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
11.6
145.9
175
203
DFF59
NOMESCO Finland
Other assessment of balance
47.3
101.4
60
14
H81.0
ICD-10 Finland
Ménière disease
35.4
67.5
43
13
N07CA01
ATC
betahistine; oral
6.1
62.7
125
247
AA1AD
NOMESCO Finland
CT of head and brain
3.6
55.4
318
1386
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.0
50.6
127
305
DFF00
NOMESCO Finland
Pure tone audiometry
4.4
49.0
146
402
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.5
40.2
112
290
H81.2
ICD-10 Finland
Vestibular neuronitis
112.4
39.2
42
*
N17
ICPC
Vertigo/dizziness
3.6
37.6
152
512
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
6.2
36.3
65
114
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.3
28.5
79
202
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.0
26.4
139
540
DFF50
NOMESCO Finland
Electronystagmography
97.6
25.9
28
*
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
90.3
23.8
26
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.4
23.8
97
323
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.0
20.8
63
171
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
43.2
20.6
25
6
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.8
20.2
116
468
H25.8
ICD-10 Finland
Other senile cataract
2.7
20.1
124
520
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
5.2
19.7
42
86
R11
ICD-10 Finland
Nausea and vomiting
3.1
19.7
92
331
R51.80
ICD-10 Finland
Headache
2.6
18.5
126
553
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
18.5
121
521
H82
ICPC
Vertiginous syndrome
6.9
18.4
29
44
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
18.4
180
931
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
5.4
17.4
35
68
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
16.8
222
1289
SPAT1263
SPAT
Sampling
2.0
16.7
291
1869
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.3
16.7
66
214
N05AB04
ATC
prochlorperazine; systemic, rectal
5.8
16.6
31
56
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
16.3
222
1301
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
15.8
160
833
G44.2
ICD-10 Finland
Tension-type headache
2.5
15.7
109
481
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
6.6
15.5
25
39
SPAT1216
SPAT
Assessment of functional ability
2.3
15.2
140
700
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.1
15.2
66
227
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
6.5
15.1
25
40
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
4.2
14.9
40
99
N03AX16
ATC
[U] pregabalin
2.1
14.9
175
965
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
14.8
222
1338
UKC02
NOMESCO Finland
Cystoscopy
2.3
14.7
135
674
PA6AD
NOMESCO Finland
CT of neck arteries
4.0
14.4
42
111
H02AB04
ATC
methylprednisolone; systemic
2.4
14.2
117
556
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
14.1
140
720
A02BC05
ATC
esomeprazole; systemic
1.9
14.0
283
1880
L28
ICPC
Limited function/disability (L)
2.1
13.9
162
888
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
13.8
162
889
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
13.7
242
1535
B01AC07
ATC
dipyridamole; systemic
3.2
13.6
55
181
R53
ICD-10 Finland
Malaise and fatigue
2.0
13.5
195
1153
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
13.3
339
2416
J37.0
ICD-10 Finland
Chronic laryngitis
4.0
13.3
38
99
M54.5
ICD-10 Finland
Low back pain
1.9
12.8
244
1580
S06.0
ICD-10 Finland
Concussion
2.4
12.6
91
407
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.1
12.4
150
829
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.3
294
2038
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
12.2
128
670
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.6
12.2
40
115
N03AE01
ATC
clonazepam; systemic
3.1
11.9
50
168
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.3
11.9
31
75
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.4
11.6
82
363
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
10.3
11.6
22
22
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
11.5
129
692
M01AE02
ATC
naproxen; oral, rectal
1.8
11.4
355
2643
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.7
11.3
26
57
M03BX02
ATC
tizanidine; oral
1.8
11.2
366
2756
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.6
11.0
70
294
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
10.8
236
1577
UDC00
NOMESCO Finland
Ear microscopy
2.7
10.7
61
243
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.2
10.7
97
478
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
10.6
128
703
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
3.1
10.6
44
147
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
10.5
100
503
SPAT1229
SPAT
Assessment of need for aid
2.5
10.3
69
297
A02BC02
ATC
pantoprazole; systemic
1.8
10.3
441
3553
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.0
10.2
46
161
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
10.2
63
261
N06AX11
ATC
mirtazapine; oral
1.8
10.1
233
1575
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.3
10.0
77
354
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
2.7
9.9
55
216
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.9
9.9
46
164
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.9
9.9
46
164
M50.3
ICD-10 Finland
Other cervical disc degeneration
4.5
9.9
24
55
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
9.8
80
377
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.0
9.8
28
73
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
9.8
81
384
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
2.5
9.7
62
261
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
9.6
126
712
H53.1
ICD-10 Finland
Subjective visual disturbances
2.7
9.6
54
214
C07AB02
ATC
metoprolol; systemic
1.8
9.5
159
973
R13
ICD-10 Finland
Dysphagia
2.5
9.5
61
258
N02BE01
ATC
paracetamol; systemic, rectal
2.3
9.4
563
4969
R4110, ,
SPAT
2.1
9.4
100
523
Z97.4
ICD-10 Finland
Presence of external hearing-aid
2.7
9.3
51
199
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
9.2
130
753
Z01.2
ICD-10 Finland
Dental examination
1.7
9.2
269
1930
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.6
9.1
53
213
N28
ICPC
Limited function/disability (N)
7.2
9.1
21
30
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.1
9.1
94
487
SPAT1254
SPAT
Administration of medicine
2.0
9.1
110
604
G47.3
ICD-10 Finland
Sleep apnoea
1.9
9.0
143
860
R51
ICD-10 Finland
Headache
2.9
8.9
42
151
T90.5
ICD-10 Finland
Sequelae of intracranial injury
8.1
8.9
19
24
N03AX09
ATC
lamotrigine; oral
3.1
8.9
37
124
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
8.9
120
684
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.8
8.8
46
175
H53.2
ICD-10 Finland
Diplopia
3.3
8.8
33
104
SPAT1097
SPAT
Recording of ECG
2.0
8.7
106
582
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.7
8.6
20
44
SPAT1104
SPAT
Monitoring of emergency patient
2.6
8.6
49
195
H93.1
ICD-10 Finland
Tinnitus
2.6
8.6
52
214
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
8.5
261
1883
TAB00
NOMESCO Finland
Lumbar puncture
3.0
8.5
38
133
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
8.4
126
741
R06AE07
ATC
cetirizine; oral
1.7
8.4
260
1879
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.7
8.4
19
41
R03BA05
ATC
fluticasone; inhalant
1.9
8.3
117
674
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
8.3
74
361
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
8.3
188
1252
N06AX21
ATC
duloxetine; oral
2.1
8.2
81
411
A06AC51
ATC
ispaghula, combinations; oral
2.7
8.2
44
170
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
8.2
244
1744
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
8.1
77
385
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.2
8.1
32
104
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.2
8.1
32
104
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
10.2
8.1
15
15
M79.6
ICD-10 Finland
Pain in limb
1.6
8.0
278
2060
P76
ICPC
Depressive disorder
2.7
8.0
42
160
D82
ICPC
Teeth/gum disease
1.7
8.0
212
1468
SPAT1153
SPAT
Removal of sutures
1.7
8.0
206
1416
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.2
8.0
67
319
SPAT1360
SPAT
Extensive global examination
2.5
7.9
50
210
L01
ICPC
Neck symptom/complaint
1.9
7.9
105
594
N03AX12
ATC
[U] gabapentin; oral
1.9
7.9
112
648
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
7.7
83
435
N29
ICPC
Neurological sympt/complt other
4.6
7.7
18
40
G43
ICD-10 Finland
Migraine
3.1
7.7
31
102
F41.09
ICD-10 Finland
UNS Panic Syndrome
4.1
7.7
21
53
NBG10
NOMESCO Finland
Acromioplastia
3.7
7.6
24
67
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
8.2
7.6
16
20
G43.9
ICD-10 Finland
Migraine, unspecified
2.8
7.6
39
147
J01MA02
ATC
ciprofloxacin; systemic
1.6
7.6
251
1832
SPAT1234
SPAT
Support of social functional capacity
2.5
7.6
47
195
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
7.6
75
381
NH1AD
NOMESCO Finland
Ankle and foot CT
4.2
7.6
20
49
N06AA09
ATC
amitriptyline; systemic
2.1
7.5
70
347
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.2
7.5
29
93
N03AF02
ATC
oxcarbazepine; oral
3.5
7.5
25
73
M79.1
ICD-10 Finland
Myalgia
1.9
7.4
98
552
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.0
7.4
33
115
N06AX16
ATC
venlafaxine; oral
2.0
7.4
90
493
N06AB10
ATC
escitalopram; oral
1.8
7.3
116
693
H02AB06
ATC
prednisolone; systemic
1.6
7.3
301
2311
DAX08
NOMESCO Finland
Fitting of hearing aid
2.3
7.3
54
244
C10AA05
ATC
atorvastatin; oral
1.6
7.2
280
2116
A04
ICPC
Weakness/tiredness general
1.8
7.2
110
649
I95.1
ICD-10 Finland
Orthostatic hypotension
2.7
7.2
37
140
N30.0
ICD-10 Finland
Acute cystitis
1.8
7.2
117
705
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.7
7.2
38
146
J01DB01
ATC
cefalexin; oral
1.7
7.2
495
4292
J01MA12
ATC
levofloxacin; systemic
1.8
7.2
125
769
109
Kela drug reimbursment
Multiple sclerosis
8.1
7.1
15
19
XKD00
NOMESCO Finland
Uroflowmetry
1.9
7.1
102
590
G04BD12
ATC
mirabegron; oral
1.9
7.1
96
546
N06AX26
ATC
vortioxetine; oral
2.5
7.1
46
196
L16
ICPC
Ankle symptom/complaint
2.0
7.0
83
450
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
7.0
85
465
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
7.0
98
563
SPAT1211
SPAT
Application of soft bandage
2.1
7.0
64
316
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
7.0
235
1716
G35
ICD-10 Finland
Multiple sclerosis
5.9
7.0
18
31
M02AA10
ATC
ketoprofen; topical
1.8
7.0
104
610
SPAT1172
SPAT
Guidance concerning hydration
3.6
6.9
22
62
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.1
6.9
71
366
R35
ICD-10 Finland
Polyuria
2.3
6.9
53
243
R10.0
ICD-10 Finland
Acute abdomen
3.3
6.9
25
77
B01AC04
ATC
clopidogrel; oral
1.8
6.8
123
763
N99
ICPC
Neurological disease other
6.2
6.8
17
28
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.0
6.8
76
404
R07.3
ICD-10 Finland
Other chest pain
2.0
6.8
75
397
C09CA06
ATC
candesartan; oral
1.7
6.8
151
993
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.9
6.8
90
508
J01FA10
ATC
azithromycin; systemic
1.6
6.8
319
2509
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.6
6.8
22
63
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.6
6.8
22
63
A04AA01
ATC
ondansetron; systemic, rectal
2.1
6.8
62
306
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.7
6.8
157
1044
L57.0
ICD-10 Finland
Actinic keratosis
1.9
6.7
90
509
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.3
6.7
51
233
N05BA12
ATC
alprazolam; oral
2.1
6.7
69
356
G04CA01
ATC
alfuzosin; oral
2.0
6.7
79
428
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.2
6.7
55
260
N01
ICPC
Headache
2.0
6.7
69
357
R00.2
ICD-10 Finland
Palpitations
2.2
6.6
57
274
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
6.6
152
1007
J01AA02
ATC
doxycycline; systemic
1.7
6.6
477
4125
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.9
6.6
30
106
F45.8
ICD-10 Finland
Other somatoform disorders
2.5
6.6
41
171
R12
ICD-10 Finland
Heartburn
2.2
6.6
57
275
XLA10, ,
NOMESCO Finland
2.9
6.5
30
107
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
5.4
6.5
18
34
L13
ICPC
Hip symptom/complaint
1.7
6.5
135
871
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
6.5
88
500
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
6.4
133
856
SPAT1262
SPAT
Handing over of treatment supplies
1.8
6.4
112
687
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.7
6.4
33
125
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
6.4
88
502
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
6.4
96
564
N05CF01
ATC
zopiclone; oral
1.6
6.3
216
1575
N86
ICPC
Multiple sclerosis
11.2
6.3
11
10
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.6
6.3
237
1765
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
6.3
397
3309
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.9
6.2
29
104
-42
ICPC
Electrical tracing
4.2
6.1
16
39
R55
ICD-10 Finland
Syncope and collapse
1.9
6.1
85
487
KCV04
NOMESCO Finland
Distension of bladder with fluid
12.7
6.1
10
8
SPAT1312
SPAT
General health counselling
1.6
6.1
185
1311
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
3.2
6.1
23
73
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
6.1
128
828
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.1
6.0
57
285
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.1
6.0
59
299
R32
ICD-10 Finland
Unspecified urinary incontinence
2.9
6.0
27
95
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
196
659
3.87
49.93
5.4
5.1
32.97
32.21
%
0.36
134
418
375
2221
2.71
32.31
5.5
4.1
37.98
76.54
ng/l
0.75
301
1692
317
1782
2.58
29.58
2.5
2.1
131.67
247.22
u/l
1.93
303
1684
76
209
4.00
24.77
3.9
4.1
24.49
25.12
mmol/l
1.24
69
195
456
3258
2.47
22.39
5.8
4.9
6.70
6.75
mmol/l
0.20
440
3099
74
217
3.73
21.96
2.2
1.9
—
—
—
0
0
70
201
3.79
21.40
2.0
1.8
—
—
—
0
0
107
407
2.96
20.82
3.5
3.4
5.13
5.14
kpa
0.05
100
392
95
339
3.12
20.66
3.4
3.6
0.94
2.18
mmol/l
1.95
69
255
396
2723
2.23
20.35
18.6
15.7
1.26
1.28
inr
0.46
334
2271
443
3292
2.18
17.31
4.3
3.3
50.08
49.73
u/l
0.02
410
3067
408
2945
2.10
17.12
7.3
6.9
1.22
1.21
mmol/l
1.05
335
2531
297
1917
2.04
16.89
3.5
3.4
1100.35
1523.71
ng/l
2.07
248
1649
273
1761
1.97
15.07
3.2
2.5
58.00
62.19
u/l
0.34
251
1626
491
3948
2.12
13.54
5.9
4.4
13.01
13.32
mm/h
0.18
450
3664
25
45
5.74
13.46
1.1
1.1
—
—
—
0
0
81
334
2.64
13.31
2.7
2.5
7.78
17.38
au/ml
—
5
26
22
36
6.30
13.01
1.1
1.1
44.66
45.84
mg/l
0.03
17
29
185
1100
1.97
12.48
2.0
1.8
1026.21
1198.98
nmol/l
1.53
128
828
242
1575
1.87
12.40
2.8
2.3
3.13
3.01
mg/l
0.25
201
1359
30
69
4.52
12.28
1.8
2.9
46.73
26.39
mg/l
0.55
11
33
452
3583
1.94
12.22
7.5
5.1
31.29
3427.15
e6/l
—
7
68
353
2593
1.83
12.13
2.6
2.2
105.56
96.63
pmol/l
2.35
220
1354
26
55
4.89
11.75
1.1
1.1
—
—
—
0
0
24
48
5.16
11.55
1.2
1.2
—
75.60
—
0
5
30
73
4.27
11.45
1.8
1.4
—
—
—
0
0
30
74
4.21
11.25
1.8
1.4
—
—
—
0
0
30
74
4.21
11.25
1.8
1.4
—
—
—
0
0
29
71
4.23
10.98
1.8
1.4
—
—
—
0
0
29
71
4.23
10.98
1.8
1.4
—
—
—
0
0
337
2493
1.76
10.82
2.8
2.5
77.83
78.60
nmol/l
0.20
292
2225
29
72
4.17
10.79
1.8
1.4
—
—
—
0
0
257
1789
1.74
9.99
2.0
1.7
20.10
20.37
nmol/l
0.09
218
1499
348
2635
1.72
9.96
6.7
6.2
1.22
1.21
mmol/l
1.32
299
2425
206
1353
1.78
9.77
2.7
2.4
—
—
—
0
0
188
1204
1.80
9.70
1.8
1.6
0.95
1.36
mg/l
1.47
136
943
22
31
7.31
9.58
1.1
1.0
—
—
—
0
0
103
551
2.04
9.12
2.1
2.0
350.15
387.70
nmol/l
0.95
84
509
49
197
2.61
8.45
1.7
1.6
18.95
14.19
u/ml
0.22
11
35
111
628
1.93
8.35
2.6
2.3
246.76
127.78
ug/g
0.85
78
491
79
395
2.14
8.34
1.9
1.7
—
—
—
0
0
18
39
4.72
7.92
1.9
1.3
—
—
—
0
0
18
39
4.72
7.92
1.9
1.3
—
—
—
0
0
372
2968
1.62
7.89
6.1
6.6
10.46
11.74
umol/l
2.60
354
2834
144
906
1.77
7.67
1.3
1.3
7.30
13.21
u/ml
0.74
43
334
154
993
1.73
7.51
2.4
2.5
11.43
12.37
umol/l
0.86
137
921
183
1237
1.68
7.50
1.7
1.8
439.64
23447330.96
pmol/l
0.99
145
998
472
4023
1.70
7.49
5.6
4.4
15.19
14.91
pmol/l
1.65
418
3640
138
865
1.76
7.43
2.3
2.5
19.42
21.84
%
1.28
122
808
145
924
1.74
7.36
2.3
2.5
2.35
2.29
g/l
0.67
127
853
483
4150
1.71
7.35
8.8
8.3
80.62
80.17
u/l
0.06
451
3919
560
5042
2.04
7.15
24.0
17.5
17.97
24.73
mg/l
7.90
497
4198
531
4733
1.80
6.51
7.4
5.5
2.00
1.95
mu/l
0.33
473
4334
174
1200
1.62
6.46
1.4
1.3
2.93
1.75
u/ml
0.36
30
305
15
23
6.65
6.37
2.6
2.0
40.35
40.21
g/l
0.02
15
23
354
2880
1.53
6.23
5.5
4.3
14.43
5.51
estimate
0.26
84
635
90
525
1.83
6.10
2.0
3.3
66.00
66.58
g/l
0.31
79
477
350
2848
1.52
6.10
5.7
4.3
0.00
0.00
estimate
0.50
81
615
16
29
5.63
6.02
2.3
2.2
—
—
—
0
0
316
2529
1.50
5.88
3.5
3.1
119.72
125.38
ug/l
0.23
287
2338
355
2913
1.50
5.83
5.4
4.3
0.08
0.51
estimate
0.41
78
603
541
4890
1.78
5.77
6.8
5.4
6.07
6.01
mmol/l
0.48
471
4451
149
1014
1.62
5.77
2.3
2.0
—
—
—
0
0
48
229
2.19
5.72
2.0
2.2
36.46
40.93
u/l
0.88
43
198
15
27
5.66
5.71
2.0
1.2
—
—
—
0
0
15
27
5.66
5.71
2.0
1.2
—
—
—
0
0
15
27
5.66
5.71
1.1
1.0
1.26
1.12
u/l
—
5
15
21
66
3.26
5.64
1.2
1.1
1.00
21.27
iu/ml
—
5
11
38
165
2.39
5.63
1.4
1.5
—
—
—
0
0
534
4835
1.70
5.33
21.1
17.5
76.66
76.35
ml/min/173m2
0.13
505
4514
38
170
2.31
5.28
1.8
1.3
—
—
—
0
0
59
315
1.96
5.23
1.4
1.2
183.84
147.05
u/ml
0.17
23
117
29
115
2.60
5.20
1.1
1.2
5.35
18.81
e6/l
0.86
17
86
528
4778
1.67
5.14
9.2
6.9
40.65
39.85
mmol/mol
1.22
469
4441
29
116
2.57
5.11
1.2
1.2
285.45
1135.48
e6/l
0.39
20
89
310
2523
1.45
5.01
3.1
2.8
—
—
estimate
—
0
0
100
636
1.68
5.01
5.9
7.6
—
—
—
0
0
561
5174
1.80
4.92
27.7
21.2
139.50
139.58
mmol/l
0.30
550
5070
339
2815
1.44
4.87
2.9
2.8
—
—
—
0
0
9
10
9.11
4.79
1.2
1.4
—
—
—
0
0
48
246
2.03
4.78
1.1
1.0
—
—
—
0
0
561
5184
1.78
4.75
27.7
21.3
3.99
3.98
mmol/l
0.39
547
5071
316
2601
1.43
4.70
4.2
4.7
34.93
35.21
g/l
0.36
281
2440
142
999
1.54
4.69
1.3
1.3
24.83
35.16
iu/ml
0.85
39
322
204
1552
1.47
4.61
5.0
3.7
0.03
0.06
estimate
0.22
61
494
362
3072
1.42
4.44
7.7
9.6
4.23
4.17
e9/l
0.19
324
2679
79
493
1.69
4.24
2.7
3.6
62.86
84.47
ng/l
2.81
60
423
515
4690
1.55
4.24
5.4
4.4
1.28
1.26
mmol/l
0.38
457
4252
47
252
1.94
4.15
1.6
1.9
1.03
2.73
ug/l
0.75
32
222
52
294
1.84
3.92
2.9
3.4
4.29
4.45
pmol/l
0.51
40
256
71
441
1.69
3.89
1.7
1.6
—
—
—
0
0
17
60
2.88
3.82
1.5
2.0
—
—
—
0
0
39
202
1.99
3.81
1.6
1.2
—
—
—
0
0
10
20
5.06
3.70
1.2
1.5
—
—
—
0
0
562
5261
1.66
3.69
15.3
12.6
24.36
24.65
u/l
0.17
537
5099
233
1880
1.38
3.62
4.6
4.2
9.74
8.80
mg/mmol
0.09
132
1165
101
697
1.54
3.60
4.4
4.2
228.55
247.94
u/l
1.23
94
661
566
5315
1.67
3.58
30.9
23.4
79.22
79.01
umol/l
0.06
560
5244
16
57
2.85
3.54
1.5
2.1
—
—
—
0
0
134
986
1.46
3.49
2.1
3.0
0.82
0.82
mmol/l
0.07
118
929
262
2164
1.36
3.48
5.6
4.3
0.02
0.04
estimate
0.57
62
518
110
782
1.49
3.41
3.8
4.9
1.03
1.04
mmol/l
0.14
93
706
571
5396
1.65
3.23
35.2
26.8
91.29
91.48
fl
0.51
566
5324
571
5397
1.65
3.22
35.4
26.9
250.01
247.68
e9/l
0.33
562
5277
12
34
3.58
3.21
1.2
1.3
—
—
—
0
0
12
34
3.58
3.21
1.2
1.3
—
—
—
0
0
571
5398
1.65
3.20
35.4
26.8
4.40
4.41
e12/l
0.09
562
5262
571
5398
1.65
3.20
36.0
27.3
39.28
39.74
%
0.94
565
5325
10
24
4.22
3.20
1.2
1.5
—
—
—
0
0
179
1407
1.38
3.20
2.9
2.8
345.72
348.55
umol/l
0.13
152
1230
205
1649
1.36
3.17
4.6
4.3
0.00
0.01
estimate
0.74
69
570
571
5401
1.64
3.16
35.6
27.0
132.60
132.69
g/l
0.05
566
5331
6
8
7.56
3.06
2.0
2.1
—
—
—
0
0
6
8
7.56
3.06
2.0
2.1
—
—
—
0
0
65
422
1.60
3.03
1.4
1.4
—
—
—
0
0
191
1530
1.36
3.01
5.9
5.9
3.36
2.63
ug/l
0.39
167
1355
9
21
4.33
3.00
1.1
1.0
—
—
—
0
0
8
18
4.49
2.80
1.8
1.3
—
—
—
0
0
43
257
1.72
2.75
2.0
2.7
7.32
7.54
g/l
0.57
36
232
43
257
1.72
2.75
2.0
2.7
4.42
4.26
g/l
0.62
36
232
43
257
1.72
2.75
2.0
2.7
3.28
3.74
g/l
1.22
36
232
5
6
8.39
2.75
1.0
1.5
—
—
—
0
0
17
72
2.40
2.74
1.1
1.3
—
0.80
nmol/l
—
0
5
27
140
1.97
2.69
1.3
1.2
—
—
—
0
0
9
24
3.79
2.68
1.8
2.0
—
—
—
0
0
9
24
3.79
2.68
1.8
2.1
—
—
—
0
0
9
24
3.79
2.68
1.8
2.0
—
—
—
0
0
227
1895
1.31
2.64
3.7
3.4
6.69
7.18
mmol/l
0.90
182
1587
10
30
3.37
2.61
1.7
1.9
—
—
—
0
0
10
30
3.37
2.61
1.7
1.9
—
—
—
0
0
10
30
3.37
2.61
1.7
1.9
—
—
—
0
0
10
30
3.37
2.61
1.7
1.9
—
—
—
0
0
85
607
1.46
2.58
3.4
3.2
3.07
1.95
mmol/l
2.71
77
516
524
4914
1.40
2.55
6.5
5.1
1.43
1.49
mmol/l
2.27
471
4501
5
7
7.19
2.55
1.0
1.3
—
—
—
0
0
22
108
2.07
2.54
1.2
1.1
11.63
10.47
u/l
0.14
17
85
9
26
3.50
2.49
1.1
1.2
—
—
—
0
0
8
21
3.84
2.47
1.5
1.6
—
—
—
0
0
534
5032
1.41
2.45
6.9
6.1
2.59
2.62
mmol/l
0.26
478
4624
31
175
1.81
2.42
1.6
1.4
251.98
287.37
ug/g
0.46
20
102
25
133
1.92
2.34
1.2
1.4
—
—
—
0
0
23
119
1.97
2.33
4.4
4.1
33.91
30.41
mg/l
0.11
14
83
94
1237
0.72
2.31
2.7
2.9
2.45
2.46
mmol/l
0.18
82
1106
24
127
1.93
2.29
1.2
1.2
—
4.19
—
0
17
39
240
1.67
2.28
2.1
2.8
2.44
3.05
g/l
3.51
32
215
23
120
1.95
2.28
2.0
1.9
173.86
4731.03
u/l
—
7
36
524
4941
1.37
2.23
6.4
5.2
4.46
4.56
mmol/l
1.32
472
4557
5
9
5.59
2.21
1.0
1.1
—
—
—
0
0
5
9
5.59
2.21
1.0
1.1
—
—
—
0
0
12
48
2.53
2.19
1.1
1.2
—
—
—
0
0
211
1781
1.28
2.18
2.9
3.0
29.11
32.91
u/l
1.37
194
1679
14
61
2.32
2.16
3.4
2.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
26
3.10
2.02
1.1
1.2
—
—
—
0
0
25
142
1.79
1.95
1.2
1.8
1.57
49.69
iu/l
—
5
52
5
11
4.57
1.94
1.2
1.4
—
—
—
0
0
6
18
3.35
1.75
1.0
1.2
—
—
—
0
0
69
513
1.39
1.73
4.1
6.3
10.01
10.41
mmol/l
0.16
62
485
21
119
1.79
1.68
2.8
3.5
21.09
3028.97
u/ml
0.81
21
113
5
14
3.59
1.62
1.0
1.1
—
—
—
0
0
5
14
3.59
1.62
1.0
1.3
—
—
—
0
0
5
14
3.59
1.62
1.0
1.1
—
—
—
0
0
75
572
1.35
1.61
2.4
2.2
0.20
0.20
g/l
0.02
69
533
32
207
1.58
1.60
2.9
3.2
—
—
—
0
0
34
224
1.55
1.58
2.2
3.1
1.38
0.89
g/l
0.26
27
192
18
102
1.79
1.46
1.6
1.9
—
—
—
0
0
29
433
0.65
1.44
1.8
2.6
55.42
62.49
ml/min/173m2
0.47
12
185
42
297
1.44
1.41
1.2
2.0
1.63
1.49
g/l
0.48
34
267
33
224
1.50
1.36
1.5
1.9
6.43
6.61
iu/ml
—
6
60
11
54
2.06
1.33
1.2
1.1
11.73
11.63
u/l
0.01
11
49
22
137
1.63
1.31
1.4
1.6
1895.07
19879.88
e6/l
3.05
14
100
6
24
2.51
1.30
1.2
1.3
192.37
173.80
pmol/l
—
6
24
14
243
0.57
1.30
1.1
1.3
—
—
—
0
0
5
18
2.79
1.28
3.2
3.3
7.96
10.07
kpa
—
5
18
5
18
2.79
1.28
3.2
3.3
4.63
4.65
kpa
—
5
18
95
779
1.26
1.24
1.5
1.5
—
—
—
0
0
10
49
2.06
1.22
1.1
1.1
108.90
101.43
pmol/l
—
10
49
43
315
1.39
1.22
1.3
1.4
—
—
—
0
0
10
50
2.02
1.17
1.1
1.0
—
—
—
0
0
0
34
0.00
1.16
0.0
1.6
—
7.34
—
0
28
5
20
2.51
1.15
1.2
1.1
1019.00
1429.35
miu/ml
—
5
20
5
21
2.39
1.09
1.0
1.3
—
—
—
0
0
10
52
1.94
1.06
1.7
1.8
—
—
—
0
0
10
52
1.94
1.06
1.7
1.7
—
—
—
0
0
10
52
1.94
1.06
1.7
1.8
—
—
—
0
0
61
485
1.29
1.04
2.0
2.4
5.79
6.44
ug/l
0.13
43
429
15
91
1.66
1.01
1.8
2.2
—
777.40
—
0
5
23
156
1.49
1.00
1.3
1.3
—
—
—
0
0
6
29
2.08
0.89
3.3
3.7
92.67
180.79
nmol/l
—
6
29
18
121
1.50
0.83
1.3
1.5
—
—
—
0
0
105
912
1.18
0.81
4.5
3.2
2.75
2.46
e6/l
0.16
67
459
17
114
1.50
0.80
1.0
1.4
144.33
243.15
miu/ml
—
9
57
9
149
0.60
0.80
1.1
1.5
—
—
—
0
0
6
33
1.83
0.79
1.0
1.5
64.00
77.52
umol/l
—
6
33
23
165
1.41
0.78
1.3
1.6
—
—
—
0
0
14
210
0.66
0.78
2.1
1.9
—
—
—
0
0
75
634
1.21
0.78
2.2
2.6
5.44
9.24
umol/l
2.99
65
552
42
333
1.28
0.77
3.0
2.4
12.80
13.03
nmol/l
0.05
37
293
13
83
1.58
0.75
1.2
1.2
—
—
—
0
0
230
2127
1.13
0.75
2.1
1.9
1.40
1.31
mmol/l
0.94
184
1754
11
170
0.64
0.71
2.4
1.9
—
—
—
0
0
5
26
1.93
0.70
2.8
5.5
—
—
—
0
0
5
26
1.93
0.70
2.2
1.3
137.40
100.81
nmol/l
—
5
16
29
222
1.32
0.69
1.5
2.8
10.50
10.62
g/l
0.04
20
196
10
61
1.65
0.69
1.2
1.1
—
—
—
0
0
57
480
1.21
0.64
4.0
3.7
1.22
1.22
mmol/l
0.52
52
418
5
29
1.73
0.64
1.0
1.2
4.54
7.24
u/l
—
5
22
10
153
0.65
0.63
1.1
1.1
—
—
—
0
0
19
138
1.39
0.63
2.0
2.5
40.39
97.34
ug/min
—
10
74
10
63
1.60
0.62
1.5
1.3
—
—
—
0
0
14
96
1.47
0.62
1.4
1.6
—
—
—
0
0
10
152
0.65
0.62
1.1
1.1
—
—
—
0
0
27
209
1.30
0.61
1.4
1.6
0.34
0.33
mg/l
0.02
11
94
10
150
0.66
0.58
1.8
1.6
—
—
—
0
0
7
113
0.62
0.58
1.6
1.6
3613.96
1010.94
mu/l
—
7
97
0
23
0.00
0.58
0.0
1.2
—
8.65
—
0
23
7
114
0.61
0.58
1.3
1.4
—
—
—
0
0
7
114
0.61
0.58
1.3
1.4
—
—
—
0
0
63
728
0.85
0.57
2.3
2.0
—
—
—
0
0
19
141
1.36
0.57
1.6
1.7
—
—
—
0
0
6
38
1.58
0.54
1.3
1.3
1.64
1.35
promille
—
6
30
18
134
1.35
0.53
1.2
1.3
—
—
—
0
0
13
92
1.42
0.51
1.1
1.3
—
—
—
0
0
74
655
1.15
0.49
2.7
4.2
3.25
30.78
ug/l
1.55
53
558
7
47
1.49
0.47
1.3
1.1
—
—
—
0
0
59
515
1.16
0.47
1.6
1.7
1.45
1.52
%
0.27
50
444
100
906
1.12
0.47
3.9
3.3
0.94
0.77
ug/l
0.44
72
621
15
111
1.36
0.47
1.4
1.6
—
—
—
0
0
7
50
1.40
0.45
1.4
1.2
—
—
—
0
0
10
140
0.71
0.43
1.4
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.9
—
2.37
—
0
6
29
345
0.83
0.39
3.0
3.2
26.45
24.28
mmol/l
3.57
29
338
63
704
0.88
0.39
8.1
6.7
1.61
1.05
mmol/l
0.58
45
580
9
68
1.33
0.37
1.2
1.7
—
—
—
0
0
19
152
1.26
0.37
1.6
1.8
—
—
—
0
0
8
116
0.69
0.37
1.1
1.2
—
52.66
—
0
15
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
180
1.23
0.36
1.8
2.3
0.52
0.39
iu/ml
—
10
105
45
397
1.14
0.34
1.8
2.1
3.71
3.31
ratio
0.97
33
321
23
191
1.21
0.34
2.6
4.2
1.17
2.73
ratio
2.13
15
114
6
47
1.28
0.32
1.2
1.8
—
—
—
0
0
6
47
1.28
0.32
1.7
1.3
—
—
—
0
0
16
128
1.26
0.32
1.4
1.6
—
—
—
0
0
221
2120
1.07
0.30
4.9
4.1
217.85
102.92
e6/l
0.45
163
1522
125
1321
0.93
0.27
2.9
2.7
6.24
6.62
e6/l
0.12
118
1217
215
2069
1.06
0.27
2.2
3.4
2.35
2.35
mmol/l
0.14
176
1856
33
291
1.14
0.26
1.6
1.8
3.81
3.35
mmol/l
1.24
19
212
48
529
0.90
0.26
2.5
2.4
88.90
33.35
u/l
0.48
40
437
5
74
0.67
0.26
1.2
1.7
—
—
—
0
0
9
74
1.22
0.25
1.0
1.0
—
—
—
0
0
14
114
1.23
0.25
1.4
1.6
—
—
—
0
0
15
124
1.21
0.24
1.1
1.1
1.47
1.60
g/l
1.45
15
124
11
88
1.25
0.22
1.5
2.2
31.36
32.60
pg
0.39
11
88
5
40
1.25
0.22
1.8
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
5
43
1.16
0.21
1.0
1.6
—
418.57
—
0
7
156
1621
0.95
0.20
4.4
3.3
0.47
0.45
e6/l
0.04
127
1207
83
788
1.06
0.17
2.1
1.9
—
—
—
0
0
15
129
1.17
0.17
1.1
1.1
0.90
0.90
g/l
0.01
15
129
8
69
1.16
0.16
2.1
1.4
—
—
—
0
0
42
389
1.09
0.16
2.0
2.1
—
—
—
0
0
39
360
1.09
0.16
1.9
2.0
—
—
—
0
0
56
596
0.93
0.16
5.0
3.6
—
—
—
0
0
71
749
0.94
0.16
1.6
1.4
—
—
—
0
0
123
1277
0.95
0.16
5.5
4.5
1.02
1.02
kg/l
0.22
94
874
104
1000
1.05
0.14
4.4
3.0
1.34
1.15
e6/l
0.16
64
549
12
106
1.13
0.10
1.6
1.5
262.16
304.86
mu/l
0.46
12
95
5
61
0.82
0.08
1.4
1.7
51.30
60.25
ug/l
—
5
53
5
62
0.80
0.08
1.2
1.1
—
—
—
0
0
7
65
1.08
0.08
1.1
2.3
62.51
62.67
u/ml
—
7
65
113
1105
1.03
0.07
6.0
4.1
92.32
398.61
ng/l
2.67
87
919
8
74
1.08
0.07
1.0
1.1
—
2.00
—
0
14
15
139
1.08
0.05
1.3
1.4
—
—
—
0
0
14
151
0.93
0.05
1.2
1.9
93.50
92.39
%
0.06
14
145
188
1887
0.99
0.00
4.4
3.5
275.02
91.70
e6/l
0.42
157
1464
15
145
1.04
0.00
1.5
1.4
—
—
—
0
0
122
1215
1.01
0.00
4.6
4.8
23.43
21.88
%
0.42
70
627
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
8.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
69
1.01
-0.00
2.4
4.3
—
—
—
0
0
5
55
0.91
-0.00
1.0
1.2
—
—
—
0
0
5
59
0.85
-0.00
1.0
1.2
80.40
42.37
u/l
—
5
53
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
51
0.98
-0.00
1.2
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
13.3
—
5.34
—
0
7
0
5
0.00
-0.00
0.0
3.6
—
57.90
—
0
5
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
9.80
—
0
5
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_VERTIGOCENT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_VERTIGOCENT | 1.227 [1.11, 1.36] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 1126 out of 2537 females with H8_VERTIGOCENT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_VERTIGOCENT | 1.266 [1.1, 1.45] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.021 |
During the follow-up period (1.1.1998 — 31.12.2019), 670 out of 1498 males with H8_VERTIGOCENT died.
Mortality risk
Mortality risk for people of age
years, who have H8_VERTIGOCENT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.097% | 0.29% |
| 5 | 0.606% | 1.603% |
| 10 | 1.518% | 4.157% |
| 15 | 2.797% | 7.829% |
| 20 | 4.847% | 13.0% |
Relationships between endpoints
↥Index endpoint: H8_VERTIGOCENT – Vertigo of central origin
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data